{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:23:24Z","timestamp":1769631804912,"version":"3.49.0"},"reference-count":31,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1136\/bjophthalmol-2013-303888","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T02:42:18Z","timestamp":1392345738000},"page":"739-745","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis"],"prefix":"10.1136","volume":"98","author":[{"given":"Dominique","family":"Bremond-Gignac","sequence":"first","affiliation":[]},{"given":"Hachemi","family":"Nezzar","sequence":"additional","affiliation":[]},{"given":"Paolo Emilio","family":"Bianchi","sequence":"additional","affiliation":[]},{"given":"Riadh","family":"Messaoud","sequence":"additional","affiliation":[]},{"given":"Sihem","family":"Lazreg","sequence":"additional","affiliation":[]},{"given":"Liliana","family":"Voinea","sequence":"additional","affiliation":[]},{"given":"Claude","family":"Speeg-Schatz","sequence":"additional","affiliation":[]},{"given":"Dahbia","family":"Hartani","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Kaercher","sequence":"additional","affiliation":[]},{"given":"Beata","family":"Kocyla-Karczmarewicz","sequence":"additional","affiliation":[]},{"given":"Joaquim","family":"Murta","sequence":"additional","affiliation":[]},{"given":"Laurent","family":"Delval","sequence":"additional","affiliation":[]},{"given":"Didier","family":"Renault","sequence":"additional","affiliation":[]},{"given":"Fr\u00e9d\u00e9ric","family":"Chiambaretta","sequence":"additional","affiliation":[]},{"name":"for the AZI Study Group","sequence":"additional","affiliation":[]}],"member":"239","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2013-303888-1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/bjo.72.10.733","article-title":"How do general practitioners manage eye disease in the community?","volume":"72","author":"McDonnell","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-303888-2","volume-title":"Morbidity statistics from general practice: fourth national survey 1991\u20131992","author":"McCormick","year":"1995"},{"key":"key-10.1136\/bjophthalmol-2013-303888-3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-3955(06)80003-9","article-title":"Bacterial conjunctivitis in pediatrics and primary care","volume":"53","author":"Mah","year":"2006","journal-title":"Pediatr Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2013-303888-4","first-page":"69","article-title":"Bacterial conjunctivitis","volume-title":"Infections of the eye","author":"Syed","year":"1986","edition":"2"},{"key":"key-10.1136\/bjophthalmol-2013-303888-5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.289.9.1097","article-title":"Centers for disease control and prevention. Pneumococcal conjunctivitis at an elementary school-Maine, September 20-December 6, 2002","volume":"289","author":"Anonymous","year":"2003","journal-title":"JAMA"},{"key":"key-10.1136\/bjophthalmol-2013-303888-6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMoa022521","article-title":"An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2013-303888-7","first-page":"473","article-title":"Topical antibiotics for acute bacterial conjunctivitis: a systematic review","volume":"51","author":"Sheikh","year":"2001","journal-title":"Br J Gen Pract"},{"key":"key-10.1136\/bjophthalmol-2013-303888-8","first-page":"CD001211","article-title":"Antibiotics versus placebo for acute bacterial conjunctivitis","volume":"9","author":"Sheikh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.1136\/bjophthalmol-2013-303888-9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/bjo.87.8.1004","article-title":"A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis","volume":"87","author":"Hwang","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-303888-10","first-page":"33","article-title":"Acute bacterial conjunctivitis","author":"Sheikh","year":"2004"},{"key":"key-10.1136\/bjophthalmol-2013-303888-11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/OED.S4866","article-title":"A European perspective on topical ophthalmic antibiotics: Current and evolving options","volume":"3","author":"Bremond-Gignac","year":"2011","journal-title":"Ophthalmol Eye Dis"},{"key":"key-10.1136\/bjophthalmol-2013-303888-12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/11208580-000000000-00000","article-title":"Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis","volume":"72","author":"Garnock-Jones","year":"2012","journal-title":"Drugs"},{"key":"key-10.1136\/bjophthalmol-2013-303888-13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/000992289703600801","article-title":"A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children","volume":"36","author":"Gross","year":"1997","journal-title":"Clin Pediatr"},{"key":"key-10.1136\/bjophthalmol-2013-303888-14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1091-8531(03)00168-X","article-title":"Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients","volume":"7","author":"Lichtenstein","year":"2003","journal-title":"J AAPOS"},{"key":"key-10.1136\/bjophthalmol-2013-303888-15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0161-6420(02)01894-8","article-title":"A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis","volume":"110","author":"Schwab","year":"2003","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2013-303888-16","first-page":"751","article-title":"Quantitative ocular microbiology: a method for the enumeration and identification of bacteria from the skin-lash margin and conjunctiva","volume":"20","author":"Cagle","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2013-303888-17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/bjo.2006.103556","article-title":"3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children","volume":"91","author":"Cochereau","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-303888-18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/sim.1425","article-title":"Non-inferiority trials: design concepts and issues\u2014the encounters of academic consultants in statistics","volume":"22","author":"D'Agostino","year":"2003","journal-title":"Statist Med"},{"key":"key-10.1136\/bjophthalmol-2013-303888-19","volume-title":"Note for guidance on clinical investigation of medicinal products in the paediatric population","author":"ICH Topic E11","year":"2001"},{"key":"key-10.1136\/bjophthalmol-2013-303888-20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/INF.0b013e3181b99fa2","article-title":"Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients","volume":"29","author":"Bremond-Gignac","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/bjophthalmol-2013-303888-21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11534380-000000000-00000","article-title":"Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials","volume":"12","author":"Comstock","year":"2010","journal-title":"Paediatr Drugs"},{"key":"key-10.1136\/bjophthalmol-2013-303888-22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(81)80754-8","article-title":"Etiology of acute conjunctivitis in children","volume":"98","author":"Gigliotti","year":"1981","journal-title":"J Pediatr"},{"key":"key-10.1136\/bjophthalmol-2013-303888-23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1553-2712.2007.tb00359.x","article-title":"Clinical features of bacterial conjunctivitis in children","volume":"14","author":"Patel","year":"2007","journal-title":"Acad Emerg Med"},{"key":"key-10.1136\/bjophthalmol-2013-303888-24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1542\/peds.69.6.695","article-title":"Conjunctivitis-otitis syndrome","volume":"69","author":"Bodor","year":"1982","journal-title":"Pediatrics"},{"key":"key-10.1136\/bjophthalmol-2013-303888-25","first-page":"26","article-title":"Bacterial etiology of conjunctivitis-otitis media syndrome","volume":"76","author":"Bodor","year":"1985","journal-title":"Pediatrics"},{"key":"key-10.1136\/bjophthalmol-2013-303888-26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.inf.0000172939.13159.3b","article-title":"Epidemiologic study of conjunctivitis-otitis syndrome","volume":"24","author":"Bingen","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/bjophthalmol-2013-303888-27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/112067210801800602","article-title":"Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis","volume":"18","author":"Denis","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-303888-28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.ophtha.2009.05.014","article-title":"Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis","volume":"116","author":"McDonald","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2013-303888-29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/112067210801800103","article-title":"Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers","volume":"18","author":"Chiambaretta","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-303888-30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2006.099275","article-title":"Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial","volume":"91","author":"Cochereau","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2013-303888-31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bjo.2009.161513","article-title":"Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness","volume":"94","author":"Huguet","year":"2010","journal-title":"Br J Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2013-303888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T15:42:58Z","timestamp":1648309378000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2013-303888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,5,17]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1136\/bjophthalmol-2013-303888"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2013-303888","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}